ABSTRACT The distribution of immunoreactive dynorphin (ir-dynorphin) has been determined in dorsal and ventral aspects of spinal cord and in dorsal root ganglia of rabbit and rat. Concentrations are highest in dorsal cord, with intermediate levels in ventral cord and low levels in dorsal root ganglia of both species. Levels of ir-dynorphin are relatively uniform over examined segments (vertebrae C2-S3) ofrabbit spinal cord and dorsal root ganglia. Gel permeation chromatography ofextracts from rabbit dorsal and ventral spinal cord and dorsal root ganglia revealed at least three immunoreactive components of differing molecular size in all three structures. Multiple unilateral or bilateral dorsal rhizotomy (vertebrae CS-Ti) in rat did not affect levels of ir-dynorphin in spinal cord. As reported [Goldstein, A. & Ghazarossian, V. E. (1980) Proce NatL Acad. Sciw USA 77,[6207][6208][6209][6210], midthoracic spinal transection was without effect. Within the spinal cord, the neuropeptide appears, most probably, to be contained in shortaxoned neurons. We surmise that this potent opioid peptide may participate in the processing ofsensory information in spinal cord.
Dynorphin, a remarkably potent opioid peptide that contains leucine enkephalin as its amino terminus, was isolated recently from porcine pituitary extract. The first 13 amino acid residues are Tyr-Gly-Gly-Phe-Leu-Arg-Arg-Ile-Arg-Pro-Lys-Leu-Lys. Dynorphin-(1-13) is as potent as natural dynorphin in the guinea pig ileum myenteric plexus-longitudinal muscle bioassay (1) . Evidence for a unique opioid receptor ofdynorphin type in two peripheral tissue preparations has recently been provided (2, 3) .
The regional distribution pattern of immunoreactive dynorphin (ir-dynorphin) in brain is different from that ofenkephalin or of any other known opioid peptide. The concentration is greatest in anterior hypothalamus, with lower levels in corpus striatum, hippocampus, neocortex, medulla-pons, and cerebellum (4) . In pituitary, ir-dynorphin is found predominantly in pars nervosa (4, 5) .
Recent observations suggest that peptide-containing neurons participate in the transmission or modification of sensory information entering the spinal cord. A large population ofcell bodies containing enkephalin-like immunoreactivity (ir-enkephalin) in the superficial layers may be of particular significance. Because opioid receptors are located, at least in part, on primary afferents, it has been suggested that enkephalin neurons presynaptically modulate small-diameter afferent fibers (6) (7) (8) . Some of these primary afferents contain substance P (9-11). Release of immunoreactive substance P is inhibited by the application of morphine or an enkephalin analogue under several in vitro (10) and in vivo conditions (12, 13) . Thus, neurons containing ir-enkephalin within the dorsal horn may act to modify transmission of noxious information by direct inhibition of neurotransmitter release from primary afferents.
We now report on the distribution and characterization ofirdynorphin in mammalian spinal cord and dorsal root ganglia. Elution patterns of ir-dynorphin on gel permeation chromatography are reported. In addition, the effects of multiple unilateral or bilateral dorsal rhizotomy or midthoracic spinal transection on spinal cord ir-dynorphin content are described. 14 days later, rats were killed by decapitation. In the case of unilateral rhizotomy, the CS-T1 segments were removed and dissected along the longitudinal axis to generate intact and rhizotomized segments. In the case of bilateral rhizotomy, the CS-T1 segments were removed and dissected along with the section immediately above (C2-4) and below (T2-4) the deafferented segment.
MATERIALS AND METHODS
Midthoracic Spinal Transection. Midthoracic spinal transection (at level 17) in rats was performed as described (4) .
Dynorphin Radioimmunoassay. Dynorphin immunoreactivity in spinal cord and dorsal root ganglia was determined by using a modification of the method described previously (14 as a peak emerging after cytochrome c, a second major component eluted after "~I-labeled (3-endorphin, and a third preceded the elution of "I-labeled a-endorphin (Fig. 1) . This profile is similar to that observed with extracts of anterior hypothalamus, an area shown to contain biologically active dynorphin-like material (5). These results suggest that the forms ofir-dynorphin seen in spinal cord are authentic and, moreover, that the immunoreactivity ascribed to the dorsal root ganglia is not artifactual.
The relationship of spinal cord ir-dynorphin to ir-enkephalin remains unclear. Because the antiserum used in this study does not recognize the enkephalins significantly [crossreactivity is less than 10-6% (1)], the presence ofeither pentapeptide cannot account for the observed levels of ir-dynorphin. On the other hand, although ir-enkephalin in spinal cord has been demonstrated by immunocytochemical techniques (16) (17) (18) (19) , the crossreactivities with dynorphin peptides of antisera used in these studies is not known. It is possible that dynorphin could account for some, or perhaps all, of the observed ir-enkephalin in spinal cord. Parallel radioimmunoassays ofenkephalins and dynorphin with specific antisera are required to clarify this point.
Our results indicate that ir-dynorphin is concentrated in the dorsal spinal cord. ir-enkephalin is also found in dorsal cord, with high levels in the substantia gelatinosa, an area ofdensely packed neurons thought to have a major role in the transmission of nociceptive information (20, 21) . This is a region where both small-diameter primary afferents terminate and opioid receptors are found in abundance (22) (23) (24) . Dynorphin in spinal cord may thus be involved in processing information related to noxious somatic or visceral events.
Dynorphin is probably contained in short-axoned neurons intrinsic to spinal cord. This supposition is supported by the observation that multiple unilateral or bilateral dorsal rhizotomy (CS-Ti) in rat did not affect levels of ir-dynorphin in cord (Table 3 ). These observations contrast with those reported for substance P, in which dorsal rhizotomy in cat resulted in a marked depletion of the neuropeptide in the spinal dorsal horn (11) . We observed also in an additional control and operated animal that midthoracic spinal transection was, as reported previously (4), without effect (sham: above T7, 16.4 pmol/g, and below T7, 15.1 pmol/g; operated: above T7, 15.7 pmol/g, and below T7, 17.3 pmol/g). Thus, neither severance of incoming sensory afferents nor transection ofdescending fibers from rostral cord affected levels of ir-dynorphin. It seems likely, then, that dynorphin-containing cell bodies are located throughout the length of spinal cord.
The presence of measurable, though low, levels of ir-dynorphin in dorsal root ganglia was unexpected. It is possible that Homogenates were incubated at this temperature for 10 min, cooled on ice, and then centrifuged at 11,000 x g for 15 min at 40C. The supernatant solutions were concentrated by lyophilization and then reconstituted in 5.0 ml (two 2.5-ml washes) of elution solvent. Routinely, 4.0 ml (representing 2.3% of the total column volume) was applied to a Sephadex G-50 column and then eluted at 10 ml/hr at 40C. Fractions (2.0 ml) were collected and aliquots were removed for determination of ir-dynorphin, expressed as dynorphin- (1- Multiple dorsal rhizotomies (CS-Ti) were conducted. Rats were killed 12-14 days postoperatively. Data, expressed as dynorphin-(1-13) equivalents, represent, in the case of unilateral rhizotomy (in which intact and rhizotomized segments are generated from the same C5-T1 segments by dissection along the longitudinal axis), means ± SEM of observations from three animals. In the case of bilateral rhizotomy (in which sham-operated and rhizotomized segments, as well as segments immediately above and below the deafferented segment, are derived from two groups of animals), data represent means ± SEM of observations from each of three animals. Differences in ir-dynorphin content are not statistically significant (P > 0.05).
dynorphin is present in cell bodies of some primary afferent fibers. Rhizotomy experiments ( 
